Ajanta Pharma Ltd.: Duloxetine Delayed-release Capsules, 60 Mg
Recall Summary Ajanta Pharma is recalling Duloxetine Delayed-Release Capsules 60 mg (NDC 27241-099-03) distributed nationwide because testing found higher-than-acceptable levels of N-nitroso-Duloxetine impurity in the medication. This is a Class II recall, meaning the impurity could potentially cause adverse health effects. The affected product was manufactured in India and sold under the Ajanta Pharma USA Inc. brand.
- Recalling firm
- Ajanta Pharma Ltd.
- Product
- Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-099-03
- Reason
- CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-04-29
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within U.S
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/d6d56e3a-9477-4b17-b73d-610dae3fd007